Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study46

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study9

Views

Views
May 20250
June 20250
July 20252
August 20251
September 20251
October 20251
November 20254
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom3
Brazil2
Austria1
Barbados1
United States1
Venezuela1
 

Top cities views

Views
Bridgetown1
Dallas1
São Paulo1
Vitória de Santo Antão1